GEN Biotechnology - Genetic Medicines and Cell Therapy Are Booming: Can Regulatory Agencies Keep Up?
June 15, 2022
Senior research analysts Geulah Livshits, PhD & Daniil Gataulin, PhD, on the regulatory landscape for Genetic Medicines & Cell Therapy companies.
GEN Biotechnology | Read more ›
Thank You!
We've received your information, and we're processing your request.
Get In Touch.
All fields required